Royal Bank Of Canada Petros Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.68 - $1.49 $38 - $84	-57 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.33 - $4.09 $2,584 - $7,946	-1,943 Reduced 97.15%	57 $0
Q2 2021 Aug 16, 2021	BUY	$2.87 - $4.11 $5,740 - $8,220	2,000 New	2,000 $6,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $6.42M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.